Trade

with

Venaxis Inc
(NASDAQ: APPY)
AdChoices
=
1.35
0.00
0.00%
After Hours :
-
-
-

Open

1.35

Previous Close

1.35

Volume (Avg)

62.71k (154.71k)

Day's Range

1.32-1.38

52Wk Range

1.17-3.88

Market Cap.

41.84M

Dividend Rate ( Yield )

-

Beta

0.83

Shares Outstanding

30.99M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 140.69k

    • Net Income

    • -12.15M

    • Market Cap.

    • 41.84M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -5,874.60

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.83

    • Forward P/E

    • -3.00

    • Price/Sales

    • 161.29

    • Price/Book Value

    • 1.48

    • Price/Cash flow

    • -3.12

      • EBITDA

      • -11.81M

      • Return on Capital %

      • -40.97

      • Return on Equity %

      • -50.10

      • Return on Assets %

      • -40.97

      • Book Value/Share

      • 0.91

      • Shares Outstanding

      • 30.99M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 5.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.46

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 13.80

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -29.74

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 73.43

            • 42.70

            • Pre-Tax Margin

            • -5,874.60

            • 11.63

            • Net Profit Margin

            • -5,874.60

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 68.20

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -6,753.30

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.07

              • 0.62

              • Current Ratio

              • 18.75

              • 1.23

              • Quick Ratio

              • 18.58

              • 0.76

              • Interest Coverage

              • -138.98

              • 5.98

              • Leverage Ratio

              • 1.18

              • 2.16

              • Book Value/Share

              • 0.91

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.75

                • 33.44

                • P/E Ratio 5-Year High

                • -303.90

                • 325.07

                • P/E Ratio 5-Year Low

                • -2.34

                • 154.73

                • Price/Sales Ratio

                • 161.29

                • 2.32

                • Price/Book Value

                • 1.48

                • 3.05

                • Price/Cash Flow Ratio

                • -3.12

                • 19.05

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -50.10

                    (-115.40)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -40.97

                    (-73.00)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • -45.30

                    (-86.10)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • -

                  • 5.07

                  • Asset Turnover

                  • 0.01

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -12.10M
                  Operating Margin
                  -8,602.85
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -3.12
                  Ownership

                  Institutional Ownership

                  27.54%

                  Top 10 Institutions

                  26.19%

                  Mutual Fund Ownership

                  11.81%

                  Float

                  99.77%

                  5% / Insider Ownership

                  10.91%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • AST Federated Aggressive Growth

                  •  

                    1,412,000

                  • 0.00

                  • 4.56

                  • Federated Kaufmann Small Cap Fund

                  •  

                    1,322,300

                  • 175.48

                  • 4.27

                  • Vanguard Total Stock Mkt Idx

                  •  

                    529,350

                  • 0.00

                  • 1.71

                  • Vanguard Instl Total Stock Market Index

                  •  

                    122,333

                  • 0.00

                  • 0.39

                  • Vanguard Extended Market Index Fund

                  •  

                    121,147

                  • 0.00

                  • 0.39

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    80,385

                  • 0.00

                  • 0.26

                  • Whitebox Market Neutral Equity Fund

                  •  

                    55,000

                  • 28.21

                  • 0.18

                  • USAA Extended Market Index Fund

                  •  

                    6,476

                  • -0.05

                  • 0.02

                  • AXA/Lord Abbett Micro Cap Portfolio

                  •  

                    5,541

                  • 0.00

                  • 0.02

                  • FlexShares Mstar US Mkt Factors Tilt ETF

                  •  

                    5,504

                  • 0.00

                  • 0.01

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Federated Global Inv Mgmt Corp

                  •  

                    2,734,300

                  • +425.83%

                  • 8.82

                  • Perkins Capital Management Inc

                  •  

                    1,128,203

                  • +4.05%

                  • 3.64

                  • GROW Partners LLC

                  •  

                    729,900

                  • -18.90%

                  • 2.36

                  • Vanguard Group, Inc.

                  •  

                    664,558

                  • +8.76%

                  • 2.14

                  • Dafna Capital Management LLC

                  •  

                    658,000

                  • +801.37%

                  • 2.12

                  • Bard Associates Inc

                  •  

                    471,700

                  • 0.00%

                  • 1.52

                  • Wells Fargo Bank NA

                  •  

                    278,890

                  • +21.84%

                  • 0.90

                  • Columbia Management Company

                  •  

                    221,177

                  • +61.71%

                  • 0.71

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Slow Growth

                  Style

                  Small Growth

                  Venaxis Inc was organized on July 24, 2000, as a Colorado corporation. In December 2012, the Company's name was changed to Venaxis, Inc., from AspenBio Pharma, Inc. The Company is engaged in development and commercialization of produ...morects that address unmet diagnostic and therapeutic needs. The Company's product candidate, APPY1, is designed to be a novel blood-based diagnostic test that, if successfully cleared to be marketed by the United States Food and Drug Administration (FDA), will aid, through the test’s negative predictive value, in the evaluation of low risk patients initially suspected of having acute appendicitis, thereby helping address the difficult challenge of triaging possible acute appendicitis patients in the hospital emergency department or urgent care settings. The APPY1, is intend...moreed to be used by emergency department and urgent care physicians to aid them in the evaluation of possible appendicitis in children, adolescent and young adult patients (ages 2 – 20) that present with abdominal pain. The FDA has regulatory marketing authority in the United States over its APPY1 products. The Company operates under ISO9001-4385 standards for cGMP manufacturing of medical devices. The Company is subject to various environmental laws pertaining to the disposal of hazardous medical waste. It contracts for disposal of hazardous waste with a licensed disposal facility.lessless

                  Key People

                  Stephen T. Lundy

                  CEO/Director/President

                  Ambassador Gail S. Schoettler,PhD

                  Chairman of the Board/Director

                  Mr. Jeffrey G. Mcgonegal

                  CFO/Chief Accounting Officer/Secretary

                  Mr. David E. Welch

                  Director

                  Daryl J. Faulkner

                  Director

                  • Venaxis Inc

                  • 1585 South Perry Street

                  • Castle Rock, CO 80104

                  • USA.Map

                  • Phone: +1 303 794-2000

                  • Fax: +1 303 798-8332

                  • venaxis.com

                  Incorporated

                  2000

                  Employees

                  23

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: